{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:02:23Z","timestamp":1792008143888,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23fk0410038h003"],"award-info":[{"award-number":["23fk0410038h003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["24A1003"],"award-info":[{"award-number":["24A1003"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijid.2026.108453","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:25:42Z","timestamp":1770164742000},"page":"108453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prolonged severe acute respiratory syndrome coronavirus 2 infection and intrahost viral evolution in a severely immunocompromised patient with human immunodeficiency virus infection: A whole-genome sequencing study"],"prefix":"10.1016","volume":"165","author":[{"given":"Akira","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8233-6653","authenticated-orcid":false,"given":"Kiyoto","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenshiro","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sadamasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuji","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108453_bib0001","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108453_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2026.108453_bib0003","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108453_bib0004","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3201\/eid2807.220467","article-title":"Persistent SARS-CoV-2 alpha variant infection in immunosuppressed patient, France, February 2022","volume":"28","author":"Fourati","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2026.108453_bib0005","doi-asserted-by":"crossref","first-page":"veac050","DOI":"10.1093\/ve\/veac050","article-title":"Recurrent SARS-CoV-2 mutations in immunodeficient patients","volume":"8","author":"Wilkinson","year":"2022","journal-title":"Virus Evol"},{"key":"10.1016\/j.ijid.2026.108453_bib0006","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S2666-5247(23)00336-1","article-title":"SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis","volume":"5","author":"Raglow","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijid.2026.108453_bib0007","doi-asserted-by":"crossref","first-page":"e1397","DOI":"10.1093\/cid\/ciab397","article-title":"Improving the outcomes of immunocompromised patients with coronavirus disease 2019","volume":"73","author":"Haidar","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108453_bib0008","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2026.108453_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2022.01.005","article-title":"SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape","volume":"30","author":"Cele","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijid.2026.108453_bib0010","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1093\/cid\/ciac548","article-title":"Persistent severe acute respiratory syndrome coronavirus 2 infection with accumulation of mutations in a patient with poorly controlled human immunodeficiency virus infection","volume":"76","author":"Maponga","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108453_bib0011","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/s41467-024-46673-2","article-title":"Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation","volume":"15","author":"Karim","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2026.108453_bib0012","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1017\/ice.2022.140","article-title":"Persistent infection with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a patient with untreated human immunodeficiency virus (HIV)","volume":"44","author":"Zhabokritsky","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2026.108453_bib0013","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1093\/cid\/ciac077","article-title":"Prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at high viral loads among hospitalized immunocompromised persons living with human immunodeficiency virus (HIV), South Africa","volume":"75","author":"Meiring","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108453_bib0014","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41423-023-01087-w","article-title":"The immune response to SARS-CoV-2 in people with HIV","volume":"21","author":"H\u00f6ft","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ijid.2026.108453_bib0015","first-page":"863","article-title":"SARS-CoV-2 humoral immunity in people living with HIV-1","volume":"45","author":"Upreti","year":"2024","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ijid.2026.108453_bib0016","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41586-021-04352-y","article-title":"Evolution of enhanced innate immune evasion by SARS-CoV-2","volume":"602","author":"Thorne","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2026.108453_bib0017","doi-asserted-by":"crossref","first-page":"e857","DOI":"10.1093\/cid\/ciab1008","article-title":"Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26.CoV2.S vaccination in people living with human immunodeficiency virus (HIV)","volume":"75","author":"Khan","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108453_bib0018","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2026.108453_bib0019","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41525-025-00463-x","article-title":"Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient","volume":"10","author":"Schmidt","year":"2025","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.ijid.2026.108453_bib0020","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/S1473-3099(22)00694-6","article-title":"Resistance of SARS-CoV-2 Omicron subvariant BA.4.6 to antibody neutralisation","volume":"22","author":"Wang","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108453_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012624","article-title":"Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection","volume":"20","author":"Schoefbaenker","year":"2024","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.ijid.2026.108453_bib0022","doi-asserted-by":"crossref","first-page":"veaf065","DOI":"10.1093\/ve\/veaf065","article-title":"Phylogenetic meta-analysis of persistent SARS-CoV-2 infections in immunocompromised individuals highlights the challenges of robust evolutionary rate estimation caused by low genetic diversity","volume":"11","author":"\u00d6versti","year":"2025","journal-title":"Virus Evol"},{"key":"10.1016\/j.ijid.2026.108453_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101154","article-title":"SARS-CoV-2 genomic diversity and within-host evolution in individuals with persistent infection in the UK: an observational, longitudinal, population-based surveillance study","volume":"6","author":"Ghafari","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijid.2026.108453_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00780-25","article-title":"Intra-host SARS-CoV-2 diversity in immunocompromised people living with HIV provides insight into the evolutionary trajectory of SARS-CoV-2","volume":"99","author":"Joseph","year":"2025","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2026.108453_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101122","article-title":"Characterisation of a persistent SARS-CoV-2 infection lasting more than 750 days in a person living with HIV: a genomic analysis","volume":"6","author":"Velasquez-Reyes","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijid.2026.108453_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106432","article-title":"Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study","volume":"90","author":"Quint","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2026.108453_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00658-25","article-title":"Immunocompromised patients with persistent SARS-CoV-2 viral shedding \u22658 weeks, clinical outcomes, and virological dynamics: a retrospective multicenter cohort study, 2020\u20132024","volume":"69","author":"de La Porte des Vaux","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2026.108453_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239403","article-title":"Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR","volume":"15","author":"Itokawa","year":"2020","journal-title":"PLOS One"},{"key":"10.1016\/j.ijid.2026.108453_bib0029","series-title":"Alternative primers for the ARTIC Network\u2019s nCov2019 Multiplex PCR","author":"Itokawa","year":"2021"},{"key":"10.1016\/j.ijid.2026.108453_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijid.2023.04.412","article-title":"Combination regimen of nirmatrelvir\/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: a case report and a scoping review of the literature","volume":"133","author":"Marangoni","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108453_bib0031","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cid\/ciad181","article-title":"Triple combination therapy with 2 antivirals and monoclonal antibodies for persistent or relapsed severe acute respiratory syndrome coronavirus 2 infection in immunocompromised patients","volume":"77","author":"Mikulska","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108453_bib0032","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3390\/antibiotics12091460","article-title":"Sequential or combination treatments as rescue therapies in immunocompromised patients with persistent SARS-CoV-2 infection in the Omicron era: a case series","volume":"12","author":"Longo","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijid.2026.108453_bib0033","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/ccr3.3786","article-title":"COVID-19: prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies","volume":"9","author":"Yousaf","year":"2021","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.ijid.2026.108453_bib0034","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41586-024-07029-4","article-title":"Prevalence of persistent SARS-CoV-2 in a large community surveillance study","volume":"626","author":"Ghafari","year":"2024","journal-title":"Nature"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:58:24Z","timestamp":1774414704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226000883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"alternative-id":["S1201971226000883"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108453","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged severe acute respiratory syndrome coronavirus 2 infection and intrahost viral evolution in a severely immunocompromised patient with human immunodeficiency virus infection: A whole-genome sequencing study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108453"}}